Kardigan Shares Rise 1.6% in Nasdaq Debut After Upsized $400M IPO
Summary
Kardigan's shares rose 1.6% in their Nasdaq debut, following an upsized $400 million initial public offering. This provides the immediate market reaction to the IPO, which was previously announced as priced and successfully raised earlier today. The positive debut performance indicates strong initial investor interest in the heart drug developer.
At the time of this announcement, KARD was trading at $17.72 on NASDAQ in the Life Sciences sector. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.